Delivering adjuvant chemotherapy to women with early-stage breast carcinoma
- 15 September 2001
- Vol. 92 (6) , 1354-1367
- https://doi.org/10.1002/1097-0142(20010915)92:6<1354::aid-cncr1458>3.0.co;2-p
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Cancer statistics, 2000CA: A Cancer Journal for Clinicians, 2000
- Geographic Variation in the Treatment of Acute Myocardial InfarctionJAMA, 1999
- Adjuvant Cyclophosphamide, Methotrexate, and Fluorouracil in Node-Positive Breast Cancer — The Results of 20 Years of Follow-upNew England Journal of Medicine, 1995
- Sequential or Alternating Doxorubicin and CMF Regimens in Breast Cancer With More Than Three Positive NodesJAMA, 1995
- Dose and Dose Intensity of Adjuvant Chemotherapy for Stage II, Node-Positive Breast CarcinomaNew England Journal of Medicine, 1994
- Two months of doxorubicin-cyclophosphamide with and without interval reinduction therapy compared with 6 months of cyclophosphamide, methotrexate, and fluorouracil in positive-node breast cancer patients with tamoxifen-nonresponsive tumors: results from the National Surgical Adjuvant Breast and Bowel Project B-15.Journal of Clinical Oncology, 1990
- Prolonged Disease-Free Survival after One Course of Perioperative Adjuvant Chemotherapy for Node-Negative Breast CancerNew England Journal of Medicine, 1989
- Adjuvant chemotherapy after conservative surgery plus irradiation versus modified radical mastectomyThe American Journal of Medicine, 1987
- A randomized comparative trial of adriamycin versus methotrexate in combination drug therapyCancer, 1978
- A comparison of cyclophosphamide, adriamycin, 5-fluorouracil (CAF) and cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, prednisone (CMFVP) in patients with metastatic breast cancer.A southeastern cancer study group projectCancer, 1977